Volume 2, Issue 3 (2016)
IEM 2016, 2(3): 20-23 |
Back to browse issues page
1- Department of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
2- Department of Parasitology and Mycology, School of Medical Sciences, Iran University of Medical Sciences, Tehran, IR Iran
2- Department of Parasitology and Mycology, School of Medical Sciences, Iran University of Medical Sciences, Tehran, IR Iran
Abstract: (10468 Views)
Background: This study was performed to determine antifungal activity of silver nanoparticles (nano-Ag) compared to voriconazole on clinical and standard strains of Aspergillus fumigatus.
Materials and Methods: Inhibitory potency of nano-Ag was determined using microtiter broth dilution method. Susceptibility tests were performed against A. fumigatus isolated from BAL (bronchoalveolar lavage) of patients who suffered from respiratory problems and compared with the strain (ATCC: 204305) by broth dilution antifungal susceptibility test of filamentous fungi approved by the Clinical and Laboratory Standards Institute M38-A. In addition, cytotoxicity effect of silver nanoparticles was studied on epithelial cell line by MTT assay.
Results: From 60 BAL samples the following strains were isolated; A. flavus (n=21), A. niger (n=3), and A. fumigatus (n=1). The minimum inhibitory concentration (MIC90) values of nano-Ag were 0.25 and 0.5 μg.mL-1 for standard strain and clinical isolates respectively. The Minimum Fungicidal Concentration (MFC) values of nano-Ag were 0.5 and 1 μg.mL-1for standard strain and clinical isolates respectively. MIC90 values of voriconazole were 0.125 and 0.25 μg.mL-1 for standard strain and clinical isolate respectively. The MFC values of voriconazole were 0.25 and 0 μg.mL-1 for standard strain and clinical isolates respectively. Silver nanoparticles exhibited low cytotoxicity in 0.25 μg.mL-1 concentration.
Conclusion: Our results showed high antifungal activity of silver nanoparticles against Aspergillus isolates. Furthermore, the availability of a wide form of nano-Ag structures can be considered as novel agents to decrease fungal burden in medical application.
Materials and Methods: Inhibitory potency of nano-Ag was determined using microtiter broth dilution method. Susceptibility tests were performed against A. fumigatus isolated from BAL (bronchoalveolar lavage) of patients who suffered from respiratory problems and compared with the strain (ATCC: 204305) by broth dilution antifungal susceptibility test of filamentous fungi approved by the Clinical and Laboratory Standards Institute M38-A. In addition, cytotoxicity effect of silver nanoparticles was studied on epithelial cell line by MTT assay.
Results: From 60 BAL samples the following strains were isolated; A. flavus (n=21), A. niger (n=3), and A. fumigatus (n=1). The minimum inhibitory concentration (MIC90) values of nano-Ag were 0.25 and 0.5 μg.mL-1 for standard strain and clinical isolates respectively. The Minimum Fungicidal Concentration (MFC) values of nano-Ag were 0.5 and 1 μg.mL-1for standard strain and clinical isolates respectively. MIC90 values of voriconazole were 0.125 and 0.25 μg.mL-1 for standard strain and clinical isolate respectively. The MFC values of voriconazole were 0.25 and 0 μg.mL-1 for standard strain and clinical isolates respectively. Silver nanoparticles exhibited low cytotoxicity in 0.25 μg.mL-1 concentration.
Conclusion: Our results showed high antifungal activity of silver nanoparticles against Aspergillus isolates. Furthermore, the availability of a wide form of nano-Ag structures can be considered as novel agents to decrease fungal burden in medical application.
Received: 2014/11/22 | Accepted: 2015/01/28 | Published: 2016/07/1
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |